Sonrotoclax, CAS 2383086-06-2

Product Description: Sonrotoclax is a potent, orally active Bcl2 inhibitor. Sonrotoclax has effective cell killing effect against a variety of lymphoma and leukemia cell lines[1].

Applications: Cancer-programmed cell death

Formula: C49H59N7O7S

References: [1]Nan HU, et, al. Methods of cancer treatment using bcl-2 inhibitor. WO2021110102A1.

CAS Number: 2383086-06-2

Molecular Weight: 890.10

Compound Purity: 99.61

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Bcl-2 Family

• Artikelnummer: MEXHY-148026-100
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-148026-100
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK